Satellos Bioscience Inc (BOATS:MSLE) Financings
Financings
| Raise | Date | In US dollars |
|---|---|---|
| Public offering of common shares and pre-funded warrants Closed: US$57.2M raised · US$10.1 a share · Leerink Partners +4 Dealers: Leerink Partners (co-lead), Guggenheim Securities (co-lead), Oppenheimer & Co. (co-lead), Bloom Burton, Bloom Burton Securities Inc. Buyers: Franklin Berger (24,750 common shares); Mark Nawacki (30,000 common shares) Insiders: Director Franklin Berger purchased 24,750 common shares; no other insiders participated. Use of proceeds: Research and development including SAT-3247 clinical trials, other discovery and pre-clinical programs, working capital and general corporate purposes | Feb 9, 2026 | |
| Warrant exercise of share purchase warrants Closed: C$1.04M raised | Sep 22, 2025 | US$754,560 |